Legal Opinion
Strayhorn v. Wyeth Pharmaceuticals, Inc.
District Court, W.D. Tennessee
Decided August 8, 2012No. Nos. 11-2058-STA-cgc, 11-2095-STA-cgc, 11-2083-STA-cgc, 11-2134-STA-cgc, 11-2060-STA-cgc, 11-2059-STA-cgc, 11-2145-STA-cgcPublishedCited by 14 opinions
1Opinion of the Court
ORDER GRANTING GENERIC DEFENDANTS’ MOTION TO DISMISS
S. THOMAS ANDERSON, District Judge.
Seven cases involving Defendant Wyeth LLC (“Wyeth”) and other pharmaceutical companies identified later in this Order are currently pending before the Court. These cases revolve around Plaintiffs’ injuries arising from their ingestion of the brand name drug Reglan or its generic version, metoclopramide. The Court will discuss the various Defendants in these cases below, but it will collectively refer to those manufacturing, distributing, marketing, selling, labeling, or designing Reglan as “the Brand Name…
2Cases cited29 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Cipollone v. Liggett Group, Inc.Supreme Court of the United States · 1992
- Medtronic, Inc. v. LohrSupreme Court of the United States · 1996
- Wyeth v. LevineSupreme Court of the United States · 2009
24 more not listed; retrieve them via the Exa API.
3Cited by14 opinions
- Sarah Speed v. Wyeth Pharmaceuticals, Inc.Court of Appeals for the Sixth Circuit · 2013
- Frazier v. Mylan Inc.District Court, N.D. Georgia · 2012
- Gardley-Starks v. Pfizer, Inc.District Court, N.D. Mississippi · 2013
- Reece v. Intuitive Surgical, Inc.District Court, N.D. Alabama · 2014
- In re Fosamax Products Liability LitigationDistrict Court, S.D. New York · 2013
9 more not listed; retrieve them via the Exa API.